A Veteran Versus Cancer

2018-03-21T21:31:57+00:00November 9th, 2017|Stories of Hope|

Ed and his dog, Molly. By Ed Fox, U.S. Army Veteran and Lung Cancer Survivor Lung cancer has been on my radar for some time now because both my father and sister died from this disease. I did everything I possibly could to prevent it: regular screenings, tests and doctor’s visits. Not even a year before I was diagnosed, I had my gallbladder removed which is where they eventually found the cancer. “Why didn’t they see the tumor [...]

FDA Approves First-Line Treatment for NSCLC with ALK Biomarker

2018-03-23T14:58:25+00:00November 7th, 2017|Hot Topics, News|

Monday, November 6, 2017 - The United States Food and Drug Administration (FDA) approved Alecensa (alectinib) as a first treatment for advanced non-small cell lung cancer that is positive for a biomarker called ALK.  Alecensa was already approved for ALK+ lung cancer that was resistant to other ALK-targeted therapies. Now, a large randomized clinical trial showed that Alecensa was more effective than previous first-line treatment.  Patients had an average of 25.7 months without their cancer progressing (getting worse) when taking [...]

No announcement available or all announcement expired.